[Skip to Content]

Upstate Active Clinical Trials

Study Title:

Preventing Early Renal Loss Follow-up Study (PERLage)

What is the purpose of the study?

The purpose of this study is to investigate the long-term effects of allopurinol treatment on kidney function in people with type 1 diabetes and mild to moderate diabetic kidney disease.

Upstate Institutional Review Board (IRB) Number:

1191874

Study Phase:

N/A

Patient Age Group:

Adults

Principal Investigator:

Ruth S Weinstock, MD, PhD

Who can I contact for more information?

Name: Jane D Bulger
Phone: 315-464-9008
Email: bulgerj@upstate.edu

Return to Previous Page || Search Again

Top